RE:Photodynamic Therapy Market Size, Report 2022 to 2030Oden6570 wrote
Photodynamic Therapy Market Size, Share, Growth, Trends, Report 2022 to 2030 | BioSpace Excellent find Oden6570 I wonder how many patients currently returning for their BCG just like our Gooseybear has to and are these people currently devoted to that treatment or will they be flocking over to TLD-1433 for 1 or 2 and done treatments. In my opinion once available to the public Theralase will be treating not only unresponsive but also the ones having to return over & over again for continued BCG treatments to the point that with SOC designation given to Theralase's TLD-1433 in a few short years will be referred to as the dominant treatment worldwide.
Who was it that foresaw the share price on this board around 700 dollars will be called one with incredible foresight but that $700 mark could take a few years after commercialization has begun.